Skip to search formSkip to main contentSkip to account menu

FTI 277

Known as: FTI-277 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Mutations of the ras gene are among the most commonly identified transforming events in human cancers, including multiple myeloma… 
Highly Cited
2000
Highly Cited
2000
Bisphosphonates are the important class of antiresorptive drugs used in the treatment of metabolic bone diseases. Although their… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Farnesyltransferase inhibitors (FTIs) represent a novel class of anticancer drugs that exhibit a remarkable ability to… 
1999
1999
The inhibitors of protein prenylation have been proposed for chemotherapy of tumors. Lovastatin, a 3-hydroxy-3-methylglutaryl… 
Highly Cited
1997
Highly Cited
1997
The mechanism by which the geranylgeranyltransferase I inhibitor GGTI-298 and the farnesyltransferase inhibitor FTI-277 inhibit… 
Highly Cited
1996
Highly Cited
1996
Many tumor cells have a greater resistance to ionizing radiation than their normal counterparts, suggesting that the development… 
Highly Cited
1995
Highly Cited
1995
Ras-induced malignant transformation requires Ras farnesylation, a lipid posttranslational modification catalyzed by…